These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 10623433

  • 1. Serum concentrations of sIL-2R, IL-6, TGF-beta1, neopterin, and zinc in chronic hepatitis C patients treated with interferon-alpha.
    Grüngreiff K, Reinhold D, Ansorge S.
    Cytokine; 1999 Dec; 11(12):1076-80. PubMed ID: 10623433
    [Abstract] [Full Text] [Related]

  • 2. The roles of serum IL-18, IL-10, TNF-alpha and sIL-2R in patients with chronic hepatitis C.
    Jia HY, Du J, Zhu SH, Ma YJ, Chen HY, Yang BS, Cai HF.
    Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):378-82. PubMed ID: 14607710
    [Abstract] [Full Text] [Related]

  • 3. Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa.
    Cacciarelli TV, Martinez OM, Gish RG, Villanueva JC, Krams SM.
    Hepatology; 1996 Jul; 24(1):6-9. PubMed ID: 8707283
    [Abstract] [Full Text] [Related]

  • 4. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C.
    Kitaoka S, Shiota G, Kawasaki H.
    Hepatogastroenterology; 2003 Jul; 50(53):1569-74. PubMed ID: 14571788
    [Abstract] [Full Text] [Related]

  • 5. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
    Czerwionka-Szaflarska M, Chrobot A, Szaflarska-Szczepanik A.
    Med Sci Monit; 2000 Jul; 6(5):964-70. PubMed ID: 11208439
    [Abstract] [Full Text] [Related]

  • 6. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
    Dejica D.
    Roum Arch Microbiol Immunol; 2001 Jul; 60(3):183-201. PubMed ID: 12165973
    [Abstract] [Full Text] [Related]

  • 7. Serum interleukin 6 concentrations in chronic hepatitis C patients before and after interferon-alpha treatment.
    Malaguarnera M, Di Fazio I, Laurino A, Ferlito L, Romano M, Trovato BA.
    Int J Clin Pharmacol Ther; 1997 Sep; 35(9):385-8. PubMed ID: 9314092
    [Abstract] [Full Text] [Related]

  • 8. Increased frequency of interferon-gamma-producing peripheral blood CD4+ T cells in chronic hepatitis C virus infection.
    Kawakami Y, Nabeshima S, Furusyo N, Sawayama Y, Hayashi J, Kashiwagi S.
    Am J Gastroenterol; 2000 Jan; 95(1):227-32. PubMed ID: 10638589
    [Abstract] [Full Text] [Related]

  • 9. Elevation of serum soluble interleukin-2 receptor levels in patients with hepatitis C virus infection.
    Kawakami Y, Hayashi J, Ueno K, Ohmiya M, Kishihara Y, Yamaji K, Kashiwagi S.
    Fukuoka Igaku Zasshi; 1997 Jul; 88(7):274-82. PubMed ID: 9267073
    [Abstract] [Full Text] [Related]

  • 10. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
    Naumnik W, Chyczewska E, Kovalchuk O, Tałałaj J, Izycki T, Panek B.
    Rocz Akad Med Bialymst; 2004 Jul; 49():246-51. PubMed ID: 15631351
    [Abstract] [Full Text] [Related]

  • 11. HCV infection in haemodialysed patients: a role for serum IL-10 and TGF-beta1 in liver damage?
    Burra P, Masier A, Morisco F, Di Leo V, Zorzi M, Senzolo M, Marchini F, Guido M, Canova D, Floreani A, Burroughs AK.
    Dig Liver Dis; 2008 Oct; 40(10):827-33. PubMed ID: 18372225
    [Abstract] [Full Text] [Related]

  • 12. Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.
    Alvarado Esquivel C, Elewaut A, Philippé J, Elewaut AE, Desombere I, Maertens G, Leroux-Roels G.
    Rev Invest Clin; 2002 Oct; 54(1):41-50. PubMed ID: 11995406
    [Abstract] [Full Text] [Related]

  • 13. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
    Ben-Ari Z, Pappo O, Druzd T, Sulkes J, Klein T, Samra Z, Gadba R, Tambur AR, Tur-Kaspa R, Mor E.
    Cytokine; 2004 Jul 07; 27(1):7-14. PubMed ID: 15207246
    [Abstract] [Full Text] [Related]

  • 14. Changes in serum lipid concentrations in patients with chronic hepatitis C virus positive hepatitis responsive or non-responsive to interferon therapy.
    Hamamoto S, Uchida Y, Wada T, Moritani M, Sato S, Hamamoto N, Ishihara S, Watanabe M, Kinoshita Y.
    J Gastroenterol Hepatol; 2005 Feb 07; 20(2):204-8. PubMed ID: 15683422
    [Abstract] [Full Text] [Related]

  • 15. Serum interleukin 2 and soluble interleukin 2 receptor in chronic active hepatitis C: effect of interferon therapy.
    Simsek H, Kadayifci A.
    J Int Med Res; 1996 Feb 07; 24(3):239-45. PubMed ID: 8725984
    [Abstract] [Full Text] [Related]

  • 16. [Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease].
    Peng Q, Wu Q, Chen CH, Hong H, Zhang LY.
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun 07; 8(3):208-10. PubMed ID: 16787593
    [Abstract] [Full Text] [Related]

  • 17. Treatment with GM-CSF and IL-2 in patients with metastatic colorectal carcinoma induced high serum levels of neopterin and sIL-2R, an indicator of immune suppression.
    Skog AL, Wersäll P, Ragnhammar P, Frödin JE, Mellstedt H.
    Cancer Immunol Immunother; 2002 Jul 07; 51(5):255-62. PubMed ID: 12070712
    [Abstract] [Full Text] [Related]

  • 18. Serum transforming growth factor-beta1(TGF-beta1) in patients with cirrhosis, chronic hepatitis B and chronic hepatitis C [corrected].
    Kirmaz C, Terzioglu E, Topalak O, Bayrak P, Yilmaz O, Ersoz G, Sebik F.
    Eur Cytokine Netw; 2004 Jul 07; 15(2):112-6. PubMed ID: 15319169
    [Abstract] [Full Text] [Related]

  • 19. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
    Cacoub P, Lidove O, Maisonobe T, Duhaut P, Thibault V, Ghillani P, Myers RP, Leger JM, Servan J, Piette JC.
    Arthritis Rheum; 2002 Dec 07; 46(12):3317-26. PubMed ID: 12483738
    [Abstract] [Full Text] [Related]

  • 20. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines.
    Tarakçioğlu M, Erbağci AB, Usalan C, Deveci R, Kocabaş R.
    Mediators Inflamm; 2003 Feb 07; 12(1):15-9. PubMed ID: 12745544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.